Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: HemaCare Corporation

Market Cap 346M 304M 280M 262M 491M 32.75B 499M 3.36B 1.3B 16.07B 1.3B 1.27B 55.85B P/E 2017
8.18x
P/E 2018 27.6x
Enterprise Value 336M 295M 272M 254M 477M 31.81B 485M 3.26B 1.26B 15.61B 1.26B 1.23B 54.25B EV / Sales 2017
1.29x
EV / Sales 2018 4.03x
Free-Float
94.17%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Operating Officer - 2002-12-31
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+2.79%-2.86% - - 346M
+0.27%+0.84%+52.03%+45.93% 129B
+2.63%-2.52%+2.17%+30.98% 83.63B
+0.91%+2.91%-4.48%+58.40% 25.49B
+1.86%-1.92%+9.72%+39.36% 21.43B
-0.47%-2.61%-15.07%-25.58% 19.95B
+1.19%-1.46%+6.95%+131.30% 15.4B
+1.51%+0.76%-1.04%+2.91% 14.5B
+0.60%+0.93%+54.71%+115.83% 13.46B
+0.73%+1.27%-11.18%-7.34% 12.68B
Average +1.20%-0.22%+10.42%+43.53% 37.31B
Weighted average by Cap. +1.09%-0.31%+22.00%+41.34%

Financials

2017 2018
Net sales 20.21M 17.76M 16.36M 15.32M 28.7M 1.91B 29.18M 196M 76.05M 939M 75.88M 74.24M 3.27B 28.51M 25.04M 23.08M 21.6M 40.47M 2.7B 41.15M 277M 107M 1.32B 107M 105M 4.6B
Net income 4.43M 3.89M 3.59M 3.36M 6.29M 420M 6.4M 43.08M 16.68M 206M 16.64M 16.28M 716M 4.52M 3.97M 3.66M 3.42M 6.41M 428M 6.52M 43.89M 16.99M 210M 16.95M 16.59M 730M
Net Debt -9.06M -7.96M -7.33M -6.86M -12.86M -858M -13.08M -88.05M -34.08M -421M -34.01M -33.28M -1.46B -9.9M -8.69M -8.01M -7.5M -14.05M -938M -14.29M -96.2M -37.24M -460M -37.15M -36.35M -1.6B
Logo HemaCare Corporation
Charles River Laboratories Cell Solutions, Inc. is a cell sourcing provider for developers of cell therapies and basic research. The Company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. It offers a comprehensive and integrated portfolio of drug development products and services available from a single global provider, spanning the continuum from early research to the support of marketed products. Its products and services include Research Models & Services, Discovery Services Safety Assessment, Laboratory Sciences, Cell and Gene Therapy CDMO Solutions, Biologics Testing Solutions, Avian Vaccine Services, QC Microbial Solutions, Scientific & Regulatory Advisory Services, and Scientific Staffing, Training & Operations Support.
Employees
-
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!